Expertise in
3
conditions

Catherine Remy-Dunyach

CHU Nîmes
Nimes, FR 
Expertise in
3
conditions
CHU Nîmes
Nimes, FR 

Overview

Catherine Remy-Dunyach practices practicing medicine in Nimes, France.

Ms. Remy-Dunyach is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Methicillin-Resistant Staphylococcus Aureus (MRSA), H Influenzae Meningitis, Osteomyelitis, and Rhabditida Infections.

She is actively involved in clinical research, co-authoring 95 peer reviewed articles and participating in 7 clinical trials.

Gender

Female

Locations

CHU Nîmes
Nimes, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Evaluation of the Intestinal Microbiota and Bacterial Translocation in Patients With Rheumatoid Arthritis
Evaluation of the Intestinal Microbiota and Bacterial Translocation in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: November 21, 2025
Intervention Type: Biological
Study of the Role of Regulator T Cells in the Pathophysiology of Childhood Henoch Schönlein Purpura
Study of the Role of Regulator T Cells in the Pathophysiology of Childhood Henoch Schönlein Purpura
Enrollment Status: Completed
Publish Date: November 19, 2025
Intervention Type: Biological
Influence of Intestinal Microbiota Implantation Parameters in the Neonatal Period in Premature Infants on Microbiota Profiles and Immune Orientation at 3 Years of Age
Influence of Intestinal Microbiota Implantation Parameters in the Neonatal Period in Premature Infants on Microbiota Profiles and Immune Orientation at 3 Years of Age
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Human and Bacterial Protease Activity As Prognostic Tool of Foot Infections in Diabetic Patients
Human and Bacterial Protease Activity As Prognostic Tool of Foot Infections in Diabetic Patients
Enrollment Status: Completed
Publish Date: December 18, 2024
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Analyse de la Composition du Microbiote Vaginal à différents Temps de la Prise en Charge en FIV et corrélation Avec le Taux de progestérone sérique le Jour du Transfert d'Embryon
Analyse de la Composition du Microbiote Vaginal à différents Temps de la Prise en Charge en FIV et corrélation Avec le Taux de progestérone sérique le Jour du Transfert d'Embryon
Enrollment Status: Completed
Publish Date: April 26, 2024
Intervention Type: Other
Evaluation of the Efficacy and Tolerance of Honey-impregnated Dressings Versus Non-impregnated Dressings in the Local Management of Pressure Ulcers: A Randomized Single-blind Trial
Evaluation of the Efficacy and Tolerance of Honey-impregnated Dressings Versus Non-impregnated Dressings in the Local Management of Pressure Ulcers: A Randomized Single-blind Trial
Enrollment Status: Terminated
Publish Date: August 09, 2021
Intervention Type: Procedure, Device
Study Phase: Not Applicable
Evaluation of Intestinal Bacterial and Fungal Translocation and Intestinal Microbiota in Febrile Neutropenic Patients in Pediatric Onco-hematology
Evaluation of Intestinal Bacterial and Fungal Translocation and Intestinal Microbiota in Febrile Neutropenic Patients in Pediatric Onco-hematology
Enrollment Status: Terminated
Publish Date: January 06, 2021
Intervention Type: Diagnostic test
View 6 Less Clinical Trials

95 Total Publications

A secreted AIP-Like peptide from Helcococcus kunzii inhibits the Agr quorum sensing system of Staphylococcus aureus.
A secreted AIP-Like peptide from Helcococcus kunzii inhibits the Agr quorum sensing system of Staphylococcus aureus.
Journal: Virulence
Published: July 03, 2026

Frequently Asked Questions about Catherine Remy-Dunyach

Is Catherine Remy-Dunyach a top-rated expert for Methicillin-Resistant Staphylococcus Aureus (MRSA)?

MediFind is an objective health platform that identifies experts based on real-world data. Catherine Remy-Dunyach is classified as an Advanced expert for Methicillin-Resistant Staphylococcus Aureus (MRSA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Catherine Remy-Dunyach participate in research or clinical trials?

Yes. Catherine Remy-Dunyach has published 95 articles and abstracts on conditions like Methicillin-Resistant Staphylococcus Aureus (MRSA). You can view a list of Catherine Remy-Dunyach's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Remy-Dunyach's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile